Prednisone withdrawal in HLA-identical living related donor transplant recipients.
Hariharan
S
S
Department of Internal Medicine, University of Cincinnati Medical Center, Ohio 45267-0585.
First
M R
MR
Munda
R
R
Penn
I
I
Schroeder
T J
TJ
Fidler
J
J
Weiskittel
P
P
Alexander
J W
JW
D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection; D006085:Graft Survival; D006680:HLA Antigens / Q000032:analysis*; D006650:Histocompatibility Testing; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D016030:Kidney Transplantation; D008055:Lipids / Q000097:blood; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D011241:Prednisone / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D014019:Tissue Donors
D006680:HLA Antigens; D008055:Lipids; D001379:Azathioprine; D011241:Prednisone; D008775:Methylprednisolone